Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Reumatismo ; 75(2)2023 Jul 17.
Artículo en Inglés | MEDLINE | ID: mdl-37462132

RESUMEN

Behçet disease (BD) is a rare systemic vasculitis of unknown etiology, primarily characterized by recurrent oral aphthous ulcers, genital ulcers, uveitis, and skin lesions. Pathergy test positivity is a nonspecific inflammatory response of the skin to trauma and supports the diagnosis. Recently, new inducers of pathergy reactions have been identified, for example, the placement of dental braces and laser hair removal. Our clinical case highlights the importance of thinking about this potential pathergy inducer in BD patients, to improve their quality of life and avoid complications.


Asunto(s)
Síndrome de Behçet , Antígeno HLA-B51 , Remoción del Cabello , Rayos Láser , Humanos , Síndrome de Behçet/complicaciones , Síndrome de Behçet/diagnóstico , Síndrome de Behçet/patología , Remoción del Cabello/efectos adversos , Rayos Láser/efectos adversos , Calidad de Vida , Piel/patología , Adulto
2.
Acta Gastroenterol Belg ; 82(1): 93-95, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30888761

RESUMEN

The authors report the case of a 76 year-old man with rheumatoid arthritis treated with prednisolone and etanercept. The patient was seen for persistent changes in liver tests lasting for six months, with a mixed pattern. The patient denied intake of new drugs or dietary/herbal supplements. Imaging studies showed mild steatosis. Additional study for chronic liver diseases only revealed positivity for anti-nuclear antibodies. Liver biopsy revealed noncaseating granulomas in some portal tracts. Consequent etiologic study for granulomatous diseases showed negative or normal results. So it was decided to suspend etanercept, with a subsequent gradual improvement on analytical parameters that normalized three months later. To date, only one case of granulomatous liver disease associated with an anti-TNF agent was described in the literature. This case also raises the question whether the development of granulomatous processes associated with anti-TNF agents has been underdiagnosed due to the presence of other concomitant immunosuppressant therapies.


Asunto(s)
Antirreumáticos/efectos adversos , Artritis Reumatoide/tratamiento farmacológico , Enfermedad Hepática Inducida por Sustancias y Drogas , Etanercept/efectos adversos , Granuloma/inducido químicamente , Hepatitis/complicaciones , Anciano , Antirreumáticos/uso terapéutico , Etanercept/uso terapéutico , Humanos , Inmunoglobulina G , Hepatopatías , Masculino , Receptores del Factor de Necrosis Tumoral , Factor de Necrosis Tumoral alfa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA